SCHEMBL574638

SCHEMBL574638

CCOC(=O)c1cnn(Cc2ccc3c(c2)N(C)CCC3)c1.CN1CCCc2ccc(Cn3cc(C(=O)O)cn3)cc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 4/20 0.57
GRM2 Q14416 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.40
ACHE P22303 2/20 0.39
HSD17B10 Q99714 2/20 0.38
CYP2C19 P33261 2/20 0.37
CYP2C9 P11712 1/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
OGA O60502 1/20 0.37
GAA P10253 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
GPR119 Q8TDV5 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL554625 0.97 KLKB1 (0.59) KLKB1GRM2ACHEHSD17B10CYP2C19
SCHEMBL554314 0.91 KLKB1 (0.62) KLKB1L3MBTL1ACHEHSD17B10POLB
SCHEMBL553932 0.84 KLKB1 (0.65) KLKB1GRM2
SCHEMBL553802 0.79 KLKB1 (0.67) KLKB1L3MBTL1HSD17B10POLBLMNA
SCHEMBL553854 0.78 HSD17B10 (0.60) KLKB1GRM2L3MBTL1HSD17B10CYP2C19
SCHEMBL20119292 0.77 RARA (0.51) ACHEHSD17B10CYP2C9POLBLMNA
SCHEMBL1909166 0.74 GRM2 (0.53) KLKB1GRM2HSD17B10LMNANPC1
SCHEMBL30589683 0.74 GRM2 (0.47) KLKB1GRM2L3MBTL1HSD17B10LMNA
SCHEMBL553848 0.73 ALDH1A1 (0.60) KLKB1GRM2L3MBTL1LMNATDP1
SCHEMBL2821953 0.73 LMNA (0.54) KLKB1GRM2HSD17B10LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601189-A1 N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES AS INHIBITORS OF PLASMA KALLIKREIN Novartis AG (CH) 2013-06-12 EP disclosed
WO-2012017020-A1 N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES AS INHIBITORS OF PLASMA KALLIKREIN NOVARTIS AG (CH) 2012-02-09 WO disclosed